About Trace amine-associated receptor 8
Trace amine-associated receptor 8 (TAAR8) is a protein
from Homo sapiens identified by UniProt accession
Q969N4, 342 residues long.
MolForge cross-references it against 0 known binders and
17 disease associations.
Target properties
| Protein name | Trace amine-associated receptor 8 |
| UniProt accession | Q969N4 |
| Gene | TAAR8 |
| Organism | Homo sapiens |
| Length | 342 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (17)
Diseases linked to this target (Open Targets).
- lung adenocarcinoma · score 0.18
- cutaneous melanoma · score 0.17
- endometrial cancer · score 0.16
- thyroid gland adenocarcinoma · score 0.16
- esophageal cancer · score 0.13
- squamous cell lung carcinoma · score 0.12
- metabolite measurement · score 0.08
- ichthyosis-hepatosplenomegaly-cerebellar degeneration syndrome · score 0.03
- Familial ocular anterior segment mesenchymal dysgenesis · score 0.03
- autosomal dominant limb-girdle muscular dystrophy type 1G · score 0.03
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q969N4-F1 | alphafold | PREDICTED | 91.21 | — |
Amino-acid sequence (342 residues)
MTSNFSQPVV QLCYEDVNGS CIETPYSPGS RVILYTAFSF GSLLAVFGNL LVMTSVLHFK QLHSPTNFLI ASLACADFLV GVTVMLFSMV RTVESCWYFG AKFCTLHSCC DVAFCYSSVL HLCFICIDRY IVVTDPLVYA TKFTVSVSGI CISVSWILPL TYSGAVFYTG VNDDGLEELV SALNCVGGCQ IIVSQGWVLI DFLLFFIPTL VMIILYSKIF LIAKQQAIKI ETTSSKVESS SESYKIRVAK RERKAAKTLG VTVLAFVISW LPYTVDILID AFMGFLTPAY IYEICCWSAY YNSAMNPLIY ALFYPWFRKA IKLILSGDVL KASSSTISLF LE
Explore Trace amine-associated receptor 8 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets